A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
Clinical trial NCT05104567 · COMPLETED
Trial details
- NCT number
- NCT05104567
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2023-07-26
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.